Skip to main content

Inhibition of ERN1 suppresses the expression of phosphoenolpyruvate carboxykinase 2 in U87MG glioblastoma cells and increases its sensitivity to glucose and glutamine deprivation Cover

.blurhash-client-img { display: none !important; }

Inhibition of ERN1 suppresses the expression of phosphoenolpyruvate carboxykinase 2 in U87MG glioblastoma cells and increases its sensitivity to glucose and glutamine deprivation

Endocrine Regulations

Volume 60 (2026): Issue 1 (January 2026)

By: Yuliia M. Viletska, Oleksandr H. Minchenko, Olena O. Khita, Myroslava Y. Sliusar, Oleh V. Halkin, Halyna E. Kozynkevych and Dmytro O. Minchenko

Open Access

|Mar 2026

Download the full article as a PDF file.

Articles in this issue

DOI: https://doi.org/10.2478/enr-2026-0008 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 61 - 71

Published online: Mar 24, 2026

Published in print: Jan 1, 2026

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Keywords:

gene expression,

ERN1 inhibition,

ERN1 endoribonuclease,

glutamine and glucose deprivation,

glioblastoma cells

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2026 Yuliia M. Viletska, Oleksandr H. Minchenko, Olena O. Khita, Myroslava Y. Sliusar, Oleh V. Halkin, Halyna E. Kozynkevych, Dmytro O. Minchenko, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 60 (2026): Issue 1 (January 2026)

Previous article